Details for New Drug Application (NDA): 074911
✉ Email this page to a colleague
NDA 074911 describes PHRENILIN WITH CAFFEINE AND CODEINE, which is a drug marketed by Valeant and is included in one NDA. Additional details are available on the PHRENILIN WITH CAFFEINE AND CODEINE profile page.
The generic ingredient in PHRENILIN WITH CAFFEINE AND CODEINE is acetaminophen; butalbital; caffeine; codeine phosphate. There are sixty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine; codeine phosphate profile page.
The generic ingredient in PHRENILIN WITH CAFFEINE AND CODEINE is acetaminophen; butalbital; caffeine; codeine phosphate. There are sixty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine; codeine phosphate profile page.
Summary for 074911
| Tradename: | PHRENILIN WITH CAFFEINE AND CODEINE |
| Applicant: | Valeant |
| Ingredient: | acetaminophen; butalbital; caffeine; codeine phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 325MG;50MG;40MG;30MG | ||||
| Approval Date: | Aug 22, 2001 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
